Heart failure drug study pulled before starting
Disease control
Terminated
This study was designed to test the safety and tolerability of a drug called JK07 in people with heart failure and a specific type of high blood pressure in the lungs. It planned to enroll 20 to 30 adults aged 18 to 85. However, the study was withdrawn before any participants wer…
Phase: PHASE2 • Sponsor: Salubris Biotherapeutics Inc • Aim: Disease control
Last updated May 17, 2026 03:59 UTC